Immunogenicity and Safety of the Third Booster Dose with mRNA-1273 COVID-19 Vaccine after Receiving Two Doses of Inactivated or Viral Vector COVID-19 Vaccine
Immunogenicity and Safety of the Third Booster Dose withmRNA-1273 COVID-19 Vaccine after Receiving Two Doses ofInactivated or Viral Vector COVID-19 Vaccine
Immunogenicity and Safety of the Third Booster Dose with mRNA-1273 COVID-19 Vaccine after Receiving Two Doses of Inactivated or Viral Vector COVID-19 Vaccine
Author
Tangsathapornpong A., Nanthapisal S., Pontan K., Bunjoungmanee P., Neamkul Y., Boonyarangkul A., Wanpen S., Fukpho W., Jitpokasem S., Tharabenjasin P., Jaru-Ampornpan P.
Affiliations
Department of Pediatrics, Faculty of Medicine, Thammasat University, Khlong Nueang, Khlong Luang, Pathum Thani12120, Thailand; Research Unit in Infectious and Immunology, Faculty of Medicine, Thammasat University, Khlong Nueang, Khlong Luang, Pathum Thani12120, Thailand; Clinical Research Center, Faculty of Medicine, Thammasat University, Khlong Nueang, Khlong Luang, Pathum Thani12120, Thailand; Thammasat University Hospital, Thammasat University, Khlong Nueang, Khlong Luang, Pathum Thani12120, Thailand; Department of Obstetrics and Gynecology, Faculty of Medicine, Thammasat University, Khlong Nueang, Khlong Luang, Pathum Thani12120, Thailand; Chulabhorn International College of Medicine, Thammasat University, Khlong Nueang, Khlong Luang, Pathum Thani12120, Thailand; Virology and Cell Technology Research Team, National Center for Genetic Engineering and Biotechnology (BIOTEC), Khlong Nueang, Khlong Luang, Pathum Thani12120, Thailand
